
In the second part of our interview, Novartis's Martina Lioi talks about using IP-HILIC and RP for lipid-siRNA impurities
When detecting and analyzing PFAS, the greatest hurdles lie in the various matrices in which PFAS are found. Custom methods and extensive expertise help to solve these issues.






